Mitochondrial genetic diseases.
Mitochondrial genetic diseases.
复制标题
DOI：
10.1097/mop.0b013e3283402e21
复制
发表时间：
2010-12
影响因子：
3.6
通讯作者：
Sondheimer N
中科院分区：
文献类型：
--
作者：
Falk MJ;Sondheimer N
线粒体疾病在个体上并不常见，但总体上对人类健康构成重大负担。原发性线粒体疾病是由线粒体DNA编码基因或核基因缺陷引起的，核基因的产物被输入到线粒体。在确定线粒体疾病的原因方面已经取得了很大的进步，但由于不同遗传实体之间的表型重叠以及标准诊断测试的复杂性和侵入性，诊断这些疾病的临床能力落后。在这篇综述中，我们评估了线粒体遗传学的新发现，线粒体疾病诊断测试的最新进展，以及线粒体疾病治疗的新想法。临床队列研究揭示了患者护理中与线粒体疾病表现相关的重要主题。在创造没有母系遗传线粒体DNA疾病风险的胚胎方面也取得了重大进展。在过去的一年中，已经确定了几种新的基于核和线粒体DNA的疾病的遗传原因。此外，线粒体生物学的基础研究也出现了新的见解，有望开发靶向线粒体疾病疗法。对线粒体生物学和疾病的研究继续提高临床诊断困扰儿科人群的异质性线粒体疾病的能力。这项研究还为未来设计有效线粒体疾病疗法的方法提供了框架。
Mitochondrial diseases are individually uncommon, but collectively pose a significant burden on human health. Primary mitochondrial disease is caused by defects in the mitochondrial DNA-encoded genes or in nuclear genes whose products are imported into the mitochondrion. Great strides have been made in determining the cause of mitochondrial disorders, but the clinical ability to diagnose these conditions lags behind because of phenotypic overlap between distinct genetic entities and the complexity and invasiveness of standard diagnostic testing. In this review, we evaluate new findings in mitochondrial genetics, recent developments in mitochondrial disease diagnostic testing, and emerging ideas for mitochondrial disease therapies. Clinical cohort studies have revealed important themes in patient care relative to manifestations of mitochondrial disease. Significant strides have also been made toward creating embryos free from the risk of maternally inherited mitochondrial DNA-based disease. Several new genetic causes of both nuclear and mitochondrial DNA-based diseases have been identified in the past year. In addition, novel insights have emerged from basic studies of mitochondrial biology that hold promise for the development of targeted mitochondrial disease therapies. Research on mitochondrial biology and disease continues to improve the clinical capacity to diagnose the heterogeneous group of mitochondrial diseases that afflict the pediatric population. This research also provides a framework for future approaches to devise effective mitochondrial disease therapies.